Here are five insights:
1. The surface-enhanced interbodies are designed for spinal fusion.
2. Under the warranty, Aesculap will give facilities a device replacement if a reoperation occurs due to a “clinically relevant delamination or the generation of impaction debris or a CT or MRI artifact caused by the device that impedes a physician’s ability to visualize adjacent anatomy.”
3. This warranty represents the first facility risk-share agreement on a titanium-enhanced PEEK interbody in the spine space, warranting against both delamination and visualization.
4. Surgeons have implanted more than 20,000 PlasmaporeXP devices, and more than 20 clinical studies exist on the devices.
5. Aesculap concurrently launched the TSpaceXP interbody system, which is coated with PlasmaporeXP surface enhancing technology.
“We created a program to demonstrate to healthcare providers that we believe in our product, our clinical data and our long-standing experience and ultimately share their goal of a lasting treatment for their patients’ chronic back issues,” said Chuck DiNardo, president, Aesculap Implant Systems.
More articles on devices:
InVivo announces 14th patient enrollee in Inspire study — 5 details
First Israeli hospital purchases EOS system — 4 things to know
Global orthopedic surgical robots market to grow at 46% CAGR through 2021 — 4 observations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
